SALT LAKE CITY, April 25, 2018 -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2018, after the stock market closes on Wednesday, May 9, 2018. The Company will hold an investor conference call at 2:30 p.m. Mountain Daylight Time (4:30 p.m. Eastern Daylight Time) that same day.
Investors interested in participating in the live call can dial (800) 239-9838 from the U.S. International callers can dial (323) 794-2551. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, May 16, 2018, by dialing (844) 512-2921 from the U.S. and entering confirmation code 1443602, or (412) 317-6671 from international locations, and entering confirmation code 1443602.
There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events-and-presentations. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN) is a pioneer in Nutrigenomics - a new science dedicated to cracking the human aging code. The company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim®, a scientifically-validated dietary supplement; TrueScience®, a line of Nrf2 infused skin care products; Petandim™ for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs; Axio® Smart Energy Drink mixes; PhysIQ™, a Smart Weight Management System; and Omega+, a 3-in-1 fish oil supplement. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Scott Van Winkle
Managing Director, ICR
(617) 956-6736
[email protected]


Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Trump Buys SpaceX Shares After Record IPO
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
SK Hynix Shares Fall as Workers Reject Wage Deal
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Nvidia Options Price in $280 Billion Earnings Swing
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Luxshare Shares Rise as First-Half Profit Jumps 18%
Tesla Raises Cybertruck Prices by $5,000 in US
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 



